Understanding this timeline helps set realistic expectations and supports treatment adherence during the critical early months of therapy
Dipeptidyl peptidase-4 inhibitors-associated bullous pemphigoid: A retrospective study of 168 pemphigoid and 9,304 diabetes mellitus patients
The FDA has responded with three waves of enforcement letters - September 2025, March 2026, and June 2026 - targeting telehealth companies for misleading GLP-1 marketing
this may be of particular concern in older patients who often experience a natural decline in renal function with age and may be more susceptible to the effects of dehydration
It is a chemical substance that shall not be used as a drug, medicine, active substance, or ingredient in any product intended for human or animal consumption
Among non-human primates (NHPs), the highest GLP-1 immunoreactivity is present in the hypothalamus, the area postrema, the NTS, and the dorsal vagal nucleus (51)